These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15665795)

  • 21. [Drug-eluting coronary stents].
    Fontos G
    Orv Hetil; 2006 Oct; 147(43):2059-66. PubMed ID: 17297752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restenosis treatment in the drug-eluting stent era.
    Presbitero P; Boccuzzi G
    Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
    Moreno R; Fernández C; Hernández R; Alfonso F; Angiolillo DJ; Sabaté M; Escaned J; Bañuelos C; Fernández-Ortiz A; Macaya C
    J Am Coll Cardiol; 2005 Mar; 45(6):954-9. PubMed ID: 15766835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus-eluting stents. (The results of the five-year use for the treatment of coronary artery disease).
    Krylov AL
    Angiol Sosud Khir; 2006; 12(4):71-82. PubMed ID: 17679960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Very late [corrected] thrombosis of a sirolimus-eluting stent.
    Henderson D; Gunalingam B
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial comment: which is the preferred drug-eluting stent?
    Brodie BR
    J Interv Cardiol; 2006 Feb; 19(1):39-42. PubMed ID: 16483338
    [No Abstract]   [Full Text] [Related]  

  • 33. Percutaneous coronary revascularization of diabetic patients in the era of drug-eluting stents.
    Kereiakes DJ; Young JJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S48-58. PubMed ID: 15665798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
    Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
    J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
    Nikolsky E; Lansky AJ; Sudhir K; Doostzadeh J; Cutlip DE; Piana R; Su X; White R; Simonton CA; Stone GW
    Am Heart J; 2009 Oct; 158(4):520-526.e2. PubMed ID: 19781409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent.
    Kandzari DE; Leon MB
    J Interv Cardiol; 2006 Oct; 19(5):405-13. PubMed ID: 17020565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy insight: diabetes and drug-eluting stents.
    Legrand V
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):143-50. PubMed ID: 17330126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of a JOMED PTFE-covered stent graft to treat a thrombotic-aneurysmatic native coronary artery following myocardial infarction.
    Kornowksi R
    Int J Cardiovasc Intervent; 2004; 6(2):91. PubMed ID: 15385210
    [No Abstract]   [Full Text] [Related]  

  • 40. The pathophysiology and burden of restenosis.
    Weintraub WS
    Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.